title: Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling.
authors.affiliation: Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
authors.forename: Noriomi
authors.initials: N
authors.lastname: Matsumura
authors.forename: Masaki
authors.initials: M
authors.lastname: Mandai
authors.forename: Takako
authors.initials: T
authors.lastname: Okamoto
authors.forename: Ken
authors.initials: K
authors.lastname: Yamaguchi
authors.forename: Shogo
authors.initials: S
authors.lastname: Yamamura
authors.forename: Tomonori
authors.initials: T
authors.lastname: Oura
authors.forename: Tsukasa
authors.initials: T
authors.lastname: Baba
authors.forename: Junzo
authors.initials: J
authors.lastname: Hamanishi
authors.forename: Hyun S
authors.initials: HS
authors.lastname: Kang
authors.forename: Shigeyuki
authors.initials: S
authors.lastname: Matsui
authors.forename: Seiichi
authors.initials: S
authors.lastname: Mori
authors.forename: Susan K
authors.initials: SK
authors.lastname: Murphy
authors.forename: Ikuo
authors.initials: I
authors.lastname: Konishi
mesh_terms: D018262:Adenocarcinoma, Clear Cell / Q000188:drug therapy* / Q000235:genetics*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use*; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D009536:Niacinamide / Q000031:analogs & derivatives; D020411:Oligonucleotide Array Sequence Analysis; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D010671:Phenylurea Compounds; D011725:Pyridines / Q000627:therapeutic use*; D000077157:Sorafenib; D023041:Xenograft Model Antitumor Assays
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib